Among more than 200 human papillomavirus (HPV) types presumed to exist, 18 ''high-risk'' HPV types are frequently found in anogenital cancer. The best studied types are HPV-16 and 18, which are only distantly related to one another and form two separate phylogenetic branches, each including six closely related types. 53, 56, and 66 form a third phylogenetic branch unrelated to HPV-16 and 18. Worldwide comparison of HPV-16 and 18 isolates revealed a distribution of variant genomes that correlated with the geographic origin and the ethnicity of the infected cohort and led to the concept of unique African, European, Asian, and Native American HPV-16 and 18 variants. Here, we address the question whether similar phylogenies are found for HPV-53, 56, and 66 by determining the sequence of the long control regions (LCR) of these HPVs in samples from Europe, Asia, and Africa, and from immigrant societies in North and South America. Phylogenetic trees calculated from point mutations and a few insertions/deletions affecting 2 -4.2% of the nucleotide sequences were distinct for each of the three HPVs and divergent from HPV-16 and 18. In contrast to the ''star-phylogenies'' formed by HPV-16 and 18 variants, 44 HPV-53 isolates represented nine variants, which formed two deep dichotomic branches reminiscent of the beginning split into two new taxa, as recently observed for subtypes of HPV-44 and 68. A total of 66 HPV-56 isolates represented 17 variants, which formed three branches preferentially containing European, Asian, and African variants. Variants of a fourth branch, deeply separated from the other three, were characterized by a 25 bp insertion and created a dichotomy rather than star-like phylogeny. As it contained isolates from cohorts in all continents, it may have evolved before the spread of humans into all continents. 18 of 31 HPV-66 isolates represented the prototype clone, which was found in all parts of the world, while the remaining 13 clones formed 11 branches without any geographic association. Our findings confirm the notion of a quantitatively limited genomic diversity of each HPV type with some correlation to the geographic origin of 0042-6822/$ -see front matter D Virology 340 (2005) 95 -104 www.elsevier.com/locate/yviro the sample. In addition, we observed in some variants of these three HPV types mutations that affect the amino acid sequence of the E6 oncoproteins and the L1 capsid protein, supporting the possibility of immunogenic and oncogenic diversity between variants of any HPV type.
Introduction
The taxonomy of papillomaviruses (PVs) based on phylogeny is now a mature field of research. PVs form a separate family and are further classified into genera and species as recognized by the International Committee on Taxonomy of Viruses (de Villiers et al., 2004) . On lower taxonomic levels, PVs are classified as types, subtypes, and variants, and molecular, clinical, and epidemiological research normally addresses PVs on these latter three levels of taxonomy. Among more than 200 different human papillomavirus (HPV) types, close to one hundred being formally described (Antonsson et al., 2000; Chan et al., 1995; de Villiers, 1989; de Villiers et al., 2004) , 18 HPV types are of particular interest as they are more likely to be associated with anogenital cancer and therefore classified as ''high-risk'' HPV types . Paradigms for the high-risk HPVs are HPV-16 and 18, which are only remotely related to one another. Each of HPV-16 and 18 form, together with six other HPV types, two separate phylogenetic branches, which are now called ''species' ' (de Villiers et al., 2004) . A third branch (species) of high-risk HPV types is formed by 53, 56, and 66. An HPV type is defined as a separate taxon, when the nucleotide sequence of its L1 gene differs from that of any other HPV type by at least 10%. The additional term ''subtype'' was defined to identify HPV genomes whose L1 nucleotide sequence is 2 -10% different from that of the closest type (de Villiers et al., 2004) . Presently, we know only of four HPV subtypes, and recent analyses of two of them have shown that these evolved dichotomically into independent taxa, i.e., into future HPV types (Calleja-Macias et al., in press) .
In contrast to the scarce occurrence of subtypes, each HPV type can be re-isolated in the form of genomic variants, whose number is small in comparison to the quasispecies formed by rapidly evolving RNA viruses. Variants of HPV types differ by less than 2% of their L1 nucleotide sequence, but slightly more in the long control region (LCR), which does not encode genes and is therefore less restricted to give rise to viable mutations (Stewart et al., 1996; Yamada et al., 1997) . Previous studies have shown that specific genomic variants have increased prevalence in some parts of the world and sometimes correlate with the predominant ethnic group of that geographic region (Deau et al., 1993; Ho et al., 1993; Ong et al., 1993; Heinzel et al., 1995; Stewart et al., 1996; Chan et al., 1997; Yamada et al., 1997) . Most notably, variants of HPV-16 and HPV-18 form phylogenetic trees with multiple short branches (''starphylogenies'') with high prevalence of variants of each branch either in Africa, or Europe, or East Asia. One branch of each type extends from East Asia into the Americas. Thus, these trees are reminiscent of the evolution and worldwide spread of the human host of the virus (Bernard, 1994) and suggested that certain variants diverged approximately at the same time when the major human ethnic groups formed.
Here, we report a study of the genomic diversity of variants of the closely related high-risk types HPV-53, 56, and 66. The three phylogenetic trees show similarities to but also differences from the patterns observed for HPV-16 and 18. Several geographic clusters of HPV-53 and 56 variants established similarities, while discrepancies include the deep dichotomic branching of the HPV-53 and 56 trees, possibly the early stage of a split into two taxa and a lack of clear geographic association of HPV-66 variants. In contrast to the HPV-16 and 18 trees, these phylogenies indicate that intratype diversification may have occurred well before and after the evolution of human ethnic groups and not necessarily in linkage to the evolution of the human host. The low prevalence of HPV-53, 56, and 66 may indicate a slower evolution and slower spread of these viruses than that observed in the more common HPV types. Our data bases confirm that each HPV type shows only modest diversification of its genome sequence and the encoded proteins, confirming that HPVs evolve slowly and could be much more accessible targets of vaccination and pharmaceutical approaches than many rapidly evolving RNA viruses. Our study also reports diversity between the E6 oncoproteins and the L1 capsid proteins of variants of each type, alerting us to the need to consider variant diversity in epidemiological, etiological, and vaccination research.
Results
Genomic diversity of HPV-53 isolates HPV-53 was originally isolated from a cervical swab of a pregnant woman without cytological or clinical abnormality (Gallahan et al., 1989) . Subsequently, HPV-53 been detected in smears graded as normal Lazcano-Ponce et al., 2001) as well as dysplastic lesions (Isacson et al., 1996; Meyer et al., 2001) and is considered a ''probable'' high risk HPV type . While it is not among the eight most common HPV types in cervical cancer , epidemiological studies have reported prevalence up to 6.3% (Lazcano-Ponce et al., 2001) .
Among 44 HPV-53 variants, we observed mutations in 21 positions, namely 20 single nucleotide exchanges and one 4 bp (GGGA) insertion. In the 501 bp segment that was phylogenetically evaluated, maximal distances between any two variants were 21 mutations (4.2%). A phylogenetic tree calculated from these variant sequences shows deeply dichotomical branching (Fig. 1) . Such dichotomy has been recently observed in the trees of the HPV subtype pairs HPV-44/55 and 68a/b (Calleja-Macias et al., 2005) , but it has not been described in a tree of HPV variants. One branch contains the HPV-53 reference clone and 15 isolates representing four variants. Most isolates of this branch originated from Africa or potential African immigrant populations. The second branch contained 28 isolates representing five variant genomes. One variant was represented in four out of five isolates from Asia (Hong Kong) but included an equal number of isolates from Scotland. Therefore, we cannot identify a phylogenetic cluster likely predominating in Asia.
Genomic diversity of HPV-56 isolates
HPV-56 DNA was originally identified by low-stringency hybridization with an HPV-31 probe, in a specimen (GU56) of cervical intraepithelial neoplasia (CIN) obtained from a woman in the Washington D.C. metropolitan area (Lorincz et al., 1989) . HPV-56 has also been found in cervical cancer and all grades of precursor lesions. Some authors believe that this type is under-represented in invasive cancer compared to preinvasive cervical lesions (Clifford et al., 2003) . It is generally considered to be a high-risk type , and while not being among the eight most common HPV types in cervical cancer, prevalence of this type is still generally observed between 1.1 -10.9% (Franceschi et al., 2005) .
The 59 HPV-56 isolates represented 17 different genomic variants based on point mutations in 25 positions and a 41 bp deletion. Maximal distances in the phylogenetically evaluated 549 bp segment (counting the deletion as a single mutation) between any two variants were 11 mutations (2%). Although we counted the 41 bp deletion only as a single mutational event, presence or absence of this segment divided the phylogenetic tree into two deep dichotomically separated branches. One branch was formed by six variants, which contained the 41 bp sequence, and included the reference clone, four closely related variants, and the remotely related variant BR4114. The other branch contained eleven variants: three variants of this branch had a high prevalence in the South African and Hong Kong cohort as well as in cohorts from Europe or presumed European immigrants and might have a specificity for geographic region or ethnicity (Fig. 2) .
Genomic diversity of HPV-66 isolates
HPV-66 was originally detected in a biopsy of a 38-yearold patient with a stage I invasive squamous-cell carcinoma of the uterine cervix (Tawheed et al., 1991) and is considered a ''probable'' high-risk type . HPV-66 has been reported with a prevalence up to 14.5% in CIN II/III (De Vuyst et al., 2003) but was not found among the eight most common types in cervical cancer .
Among the HPV-66 variants, there were seventeen nucleotide exchanges and one 2 bp insertion, with a total of 12 different variants and maximal distances of 16 mutations in the 621 bp (2.6%) of the phylogenetically evaluated segment. 18 of the 31 isolates contained the HPV-66 reference clone, and the other eleven variants did not show any geographic clustering. The most distantly related variant came from a patient from Morocco, a country whose intratype HPV diversity has never been studied before ( Fig. 3) .
Diversity in the E6 oncogene and a conserved part of the L1 gene
In order to evaluate the potential for functional changes of HPV proteins, whose genes are linked to LCR variation, we compared HPV-53, 56, and 66 variants selected from remote branches of the phylogenetic tree and determined the sequence of their E6 genes and the corresponding E6 oncoproteins as well as the sequence of that part of the L1 gene that is bracketed by the MY09/11 amplification primers, encoding about a third of the major capsid protein.
These sequence data are summarized in Fig. 4 . Surprisingly, the E6 genes of HPV-53 variants showed significant distances between any two variants and between the variants and the reference clone, namely up to 16 nucleotides (3.6% of the nucleotide sequence), approaching the diversity of the LCR. In the case of one variant (ED1817), this affected eleven amino acid residues or 7.3% of the E6 oncoprotein. Diversity was much lower in the case of HPV-56 and 66, with maximal distances among any two variants of seven and six nucleotides (1.5 and 1.3%). In many cases, these changes did not affect the amino acid sequence, while one, two, and three amino acids were exchanged in others. Seven, six, and six, respectively, nucleotides were affected in the L1 gene segment, amounting to diversities of 1.6 and 1.3% and affecting normally none of the amino acids, but leading in some variants to one and two amino acid exchanges.
Discussion
The high-risk HPV types involved in anogenital carcinogenesis form three phylogenetic groups (now called ''species''), two of which are affiliated with HPV-16 and HPV-18 (HPV species 9 and 7, respectively), and the third consisting of the little studied HPV types 30, 53, 56, and 66 (HPV species 6) (de Villiers et al., 2004) . It was the objective of our research to analyze this latter group, on the one hand, to investigate whether past models of intratype diversification of HPV types, built largely on the paradigms of HPV-16 and 18, but possibly supported by HPV-31 and 35 (Calleja-Macias et al., 2004) , would apply to all genital and cancer associated HPVs, and on the other hand, to begin the establishment of a data base for future epidemiological, etiological, pharmaceutical, and vaccination studies should the genomic diversity affect the virally encoded proteins.
The most important outcome of this study is the low level of genomic distances (2 -4.2%) that were observed for the various geographic isolates of HPV-53, 56, and 66. This is a remarkable observation when one considers that the LCR is under less mutations restrictions and therefore more diverse in sequence than coding regions of the HPV genome. This corresponded to a much lower diversity of the E6 and L1 genes for the most distant variants of each type. This finding may imply that normally only moderate functional differences exist between variants within each type, which is of relevance for epidemiological, etiological, pharmaceutical, and vaccination research. These small intragenic mutations may, however, lead to functional change, which are particularly likely to be expected from the highly diverse HPV-53 E6 variants, one showing eleven amino acid exchanges. It should be noted that transcriptional as well as epidemiological studies have identified quite significant functional differences between variants of HPV-16, which seem to stem from diversity in the LCR as well as in genes (Stewart et al., 1996; Yamada et al., 1997; Xi et al., 1997 Xi et al., , 1998 Kammer et al., 2000 Kammer et al., , 2002 Villa et al., 2000; Sichero et al., 2005) .
Phylogenetically, it is remarkable that most HPV types investigated so far show a similar and very limited diversity of genomes. This also appears to apply to HPV-53, 56, and 66. Each isolate in the current study was typed in the respective laboratory of origin by amplification with consensus primers and hybridization to type-specific probes. The two laboratories at the Ludwig Institute in Sao Paulo and at the University of California Irvine, which centrally evaluated all samples, were able to amplify with separate type-specific primers almost 100% of the samples. Therefore, we are confident that no hypothetical highly diverse variants were lost due to primer design problems.
To date, only four HPV types had given rise to subtypes, namely HPV-20, 34, 44, and 68 as well as two ape PV (Van Ranst et al., 1992; de Villiers et al., 2004) . We recently investigated two of these, HPV-44 and 68, and found distances of up to 10% of the LCR sequences between the prototypes and the subtypes (Calleja-Macias et al., 2005) . Each of the subtypes has evolved by a dichotomic split, giving rise to clusters of closely related variants, each cluster representing one of the two subtypes. All other HPV types studied, namely HPV-2, 5, 6, 11, 16, 18, 27, and 57 (Deau et al., 1993; Ho et al., 1993; Ong et al., 1993; Heinzel et al., 1995; Stewart et al., 1996; Chan et al., 1997; Yamada et al., 1997) , gave rise to multiple short branches, which we refer to as ''star-phylogenies''. Interestingly, our study of HPV-53 and 56 showed a dichotomic branching pattern similar to that observed for subtypes pointing to evolutionary processes that may lead to new HPV subtypes and eventually types.
The process that gives rise to phylogenetic branches, be it the short branches typical of many HPV variants, or the dichotomic branches of subtypes, or the branching events that lead to new HPV types, are not well understood. Processes such as simple genetic drift and some positive selection would possibly suffice to explain these patterns since variants with favorable properties (such as faster replication, more efficient infection) would over time predominate in a population, and less fit variants would arithmetically disappear, without hypothetical competition or selection. The quantitative limitation to diversification of each HPV type may be best explained by a genetic bottleneck. For example, the human population at the origin of the human host species may have been a very small number of individuals, limiting the number and therefore also diversity of HPV genomes that entered the subsequently expanding population.
Lastly, we did observe a limited amount of specificity of variants for geographic and ethnic origin, but not as strictly correlative as in the case of HPV-16 and HPV-18 (Ho et al., 1993; Ong et al., 1993 , Stewart et al., 1996 Yamada et al., 1997) . It may be noteworthy that this poorer correlation was observed with HPV types that are rare in comparison to HPV-16 and HPV-18. It is not understood why different HPV types have quite divergent prevalence, but intuitively one may propose that abundant HPV types may multiply and spread faster than rare types. This could imply that the diversification of rare HPV types took place on a different time scale to that of HPV-16 and 18 that is not consistent with the spread of human ethnic groups around the world. For instance, the observation that the HPV-66 prototype was found abundantly in patients from South Africa and Scotland could be explained if the HPV-66 genome as it exists today was already extant more than 100,000 years ago. Fig. 1 . The intratype diversity of HPV-53. The phylogenetic trees represent the relationship between HPV-53 variants based on a 501 bp segment of the long control region (LCR). The large tree is based on the UPGMA, the small tree on the neighbor joining algorithm. Samples were obtained from Sao Paulo in Brazil (BR), Hong Kong (HK), Monterrey in Mexico (MX), Edinburgh in Scotland (ED), Cape Town in South Africa (SA), Oklahoma, United States (OK), and Mali (ML). The natural root of this UPGMA tree and those shown in Figs. 2 and 3 are not known but generated by the computer program at the mid-point between the deepest branches. Fig. 2 . The intratype diversity of HPV-56. The phylogenetic trees represent the relationship between HPV-56 variants based on a 549 bp segment of the long control region (LCR). The large tree is based on the UPGMA, the small tree on the neighbor joining algorithm. Origin of samples as in Fig. 1 , three samples were from Heidelberg, Germany (HE). Fig. 3 . The intratype diversity of HPV-66. The phylogenetic trees represent the relationship between HPV-66 variants based on a 621 bp segment of the long control region (LCR). The large tree is based on the UPGMA, the small tree on the neighbor joining algorithm. Origin of samples as in Fig. 1, and 
Materials and methods

Sample collection
In order to explore the intratype phylogeny of HPV-53, 56, and 66, we examined the sequence diversity within the long control region (LCR) of isolates from six geographically and ethnically remote cohorts from Brazil (BR), Hong Kong (HK), Mexico (MX), Scotland (ED, Edinburgh), South Africa (SA), Oklahoma, and United States (OK) with inclusion of some samples from Germany (HE, Heidelberg), Mali (ML), and Morocco (MR). All patients from Hong Kong were ethnic Chinese, all samples from South Africa were obtained from Cape Town patients with an exclusive or predominant African genetic background. All samples had been collected during ongoing diagnostic and epidemiological research of cervical smears in studies that are unrelated to the objectives of our project. No patient was sampled solely for the purpose of our research.
HPV-53
Genomic segments of HPV-53 were amplified by polymerase chain reaction (PCR) using the primers HPV-53-F, 5V-TTTGCATGTTGTTAATAAATAT-3V, and HPV-53-R, 5V-AGTAGGATTGTTACTTTC-3V, which generated a 602 bp segment, between the genomic positions 7270 and 15. The amplicons were directly sequenced with the primers HPV-53-Fa, 5V-TGGTGTCCCTAGGCAGTTGG-3V, and HPV-53-R. The genomic sequence was established for 501 bp of the 602 bp fragment. The sequences of all 44 isolates are published with the GenBank access codes AY949045 -AY949087. In order to exclude possible PCR artifacts, all samples were amplified twice, and both strands were sequenced twice. The same precaution applied to the treatment of the HPV-56 and HPV-66 samples.
HPV-56
Genomic segments of HPV-56 were amplified by PCR with the primers 56-F (5V-TGTGTCATTATTGTGG-CTTTTGTTTTGT-3V) and 56-R (5V-AGCTGCCTTTTA-TATGTACCGTTTTC-3V), which generated a 603 bp segment between the genomic positions 7323 and 81. The genomic sequence was established for 549 bp of the 603 bp fragment. The sequences of all 59 isolates are published with the GenBank access codes AY949088 -AY949146.
HPV-66
Genomic segments of HPV-66 were amplified by PCR with the 66-F (5V-AACGATAGTTGTGTGTTGTG-3V) and 66-R (5V-ACCTGTTTTAGCACGACC-3V), resulting in a 659 bp fragment between genomic positions 7151 and 7810. The genomic sequence was established for 621 of the 659 bp fragment. The sequences of all 31 isolates are deposited in GenBank under the access codes AY949147-AY949176.
Amplification with E6 and L1 consensus primers
The HPV-53, 56, and 66 E6 genes were amplified with the consensus primers LCR-S (5V-AAGGGAGTAACC-GAAAACGGT-3V) and E7-AS (5V-TCATCCTCCTCCTCT-GAG-3V) (Noda et al., 1998) , which generated a 650 bp segment. The genomic sequence was established for 464 bp (HPV-53 and 56) and 467 bp (HPV-66), respectively, of these 650 bp. 450 bp fragments of the L1 genes were amplified with the consensus primers MY09/MY11 (Bauer et al., 1991; Bernard et al., 1994) , and the genomic sequence was established for 390 bp of these 450 bp. The sequences of all isolates are published with the GenBank access codes DQ007159-DQ007188.
PCR amplification, sequence analysis, and phylogenetic evaluations
The PCR amplicons were electrophoretically separated on 2% agarose gel, purified with ExoI and alkaline phosphatase (USB, Cleveland OH), and applied to enzymatic extension reactions for DNA sequencing using the ABI PRISM BigDye Cycle Sequencing Kit (AB Applied Biosystems). Both strands were sequenced with the same forward and reverse primers as those used for PCR amplification of the LCR unless stated differently. The sequencing reactions were purified by ethanol/sodium acetate precipitation and then run on an ABI Prism 3100 sequencer. The mutations were analyzed and determined by the ALIGN program at the GENESTREAM network server (Pearson et al., 1997 , http:// www2.igh.curs.fr/bin/align-guess.cgi). The Neighbor-joining and unweighted pair-group method with arithmetic average (UPGMA) trees were constructed using Mega version 2.1.
